Healthcare Analytical Testing Services Market Expected to Reach $ 9.8 Billion by 2026, from $ 5.6 Billion in 2021, at a CAGR of 11.9%

0

Market growth is driven by the growing trend of analytical testing outsourcing by pharmaceutical and medical device companies, an increasing number of clinical trials and the growing acceptance of the QbD approach in research and development. pharmaceutical manufacturing.

New York, October 11, 2021 (GLOBE NEWSWIRE) – Reportlinker.com Announces the Publication of the “Healthcare Analytical Testing Services Market By Type, End User – Global Forecast to 2026” – https: //www.reportlinker .com / p05365435 /? utm_source = GNW

The batch release testing segment is expected to grow at the highest rate, by type, in the healthcare analytical testing services market, during the forecast period.
On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development and validation, stability testing, batch release testing, raw material testing, microbial testing, and environmental monitoring services.
During the forecast period, the Batch Release Testing segment is expected to grow at the highest rate, by type. The strong growth in this segment can be attributed to the usefulness of these services in ensuring that pharmaceutical products comply with regulations and specifications in the Marketing Authorization (MA) or Clinical Trial Dossier ( CTD).

In the batch release testing segment, the dissolution testing services segment holds the highest market share and experiences the fastest growth during the forecast period.

In the bioanalytical testing services segment, cellular testing services hold the highest share of the market during the forecast period.
On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development and validation, stability testing, batch release testing, raw material testing, microbial testing, and environmental monitoring services.
The bioanalytical testing services segment holds the highest share during the forecast period. Within this segment, cellular testing services hold the highest market share.

This high market share can be attributed to the use of cellular assays in high throughput screening, which has increased due to their ability to provide relevant in vivo biological information, thereby speeding up the drug discovery process.

The medical device company segment is expected to grow at the highest rate, per end user, in the healthcare analytical testing services market, during the forecast period.

In this report, the healthcare analytical testing services market has been segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and contract research organizations (CROs), by end user. The segment of medical device companies is expected to grow at the highest rate of the market during the forecast period.

The high growth rate of the segment can be attributed to growing OEM demand for more services and expertise, evolving regulatory scenarios, technological advancements in medical devices, and adoption of point-of-service testing ( POC) leading to the demand for analytical testing in healthcare. services among medical device companies.

APAC is expected to grow at the highest rate in healthcare analytical testing services market, by region, during the forecast period
The healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The Asia-Pacific region is expected to grow at the highest rate, by region, during the forecast period.

This high growth rate can be attributed to the significant growth opportunities in emerging Asian countries and their declining production costs by moving drug manufacturing and R&D operations to the region, making this region a major destination for drug discovery and development. In addition, the large number of qualified researchers and the low cost of operations in APAC countries, such as India and China, have supported this trend.

A breakdown of the major healthcare analytical testing services market players referred to in this report is provided below:
• By type of business: level 1 at 40%, level 2 at 35% and level 3 at 25%
• By designation: C level – 45%, director level – 35% and others – 20%
• By region: North America: 45%, Europe: 25%, Asia-Pacific: 15%, Latin America: 10%, Middle East and Africa: 5%

The major players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (United States), SGS SA (Switzerland), Charles River Laboratories (United States), WuXi AppTec Co. Ltd. (China), PPD, Inc. (US), Element Materials Technology (UK), Thermo Fisher Scientific (US), Pace Analytical Services, LLC. (United States), Intertek Group LLC. (United Kingdom), Merck KGaA (Germany), Danaher Corporation (United States), Source BioScience (United Kingdom), Almac Group (United Kingdom), ICON plc (Ireland), Frontage Laboratories, Inc. (United States) USA), STERIS plc (USA), Sartorius AG (Germany), ALS Life Science (USA), Syneos Health (USA), Medpace Holdings, Inc. (USA), Cinven (LGC Limited) (UK), Anacura (Belgium), Impact Analytical (US) and CD BioSciences (US).

Research coverage
The report analyzes the market for various healthcare analytical testing services and their adoption model. It aims to estimate the market size and future growth potential of healthcare analytical testing services and different segments such as by type, end user and region.

The report also includes an in-depth competitive analysis of key players in this market along with their company profiles, services, and recent developments.

Reasons to buy the report
The report will enrich established companies as well as new entrants / small businesses to gauge the pulse of the market which, in turn, would help them get a bigger share. Companies purchasing the report can use one or a combination of the five strategies mentioned below to strengthen their presence in the market.

This report provides information on the following pointers:
• Market Penetration: Comprehensive insight into the service portfolios offered by the major players in the global healthcare analytical testing services market.
• Service Development / Innovation: Detailed information on the upcoming trend and service launches in the global healthcare analytical testing services market.
• Market Development: Comprehensive information on lucrative emerging regions by type, end users and region.
• Market diversification: Comprehensive insight into new services, growing geographies, and recent developments in the global healthcare analytical testing services market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of the major players in the global Healthcare Analytical Testing Services Market.
Read the full report: https://www.reportlinker.com/p05365435/?utm_source=GNW

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001


Source link

Leave A Reply

Your email address will not be published.